The agreement provides for the sale of the Company's equity stake for a deferred consideration amounting to approximately €208m, which corresponds to the most recently audited net book value of the participation, subject to potential adjustments. The Company will revert with a comprehensive update following the signing of the agreement, which is promptly anticipated.